Xtant Medical Adds Trivium Shaped Bone Grafts

Xtant Medical Holdings has commercially launched Trivium Shaped, expanding its Trivium allograft line with pre-formed boats and strips designed to remove preparation time at the point of use. Announced this week, the launch widens the company’s existing range, which has been built around a sculptable composite allograft format since April 2025. It also marks one of the first major commercial moves from Xtant since its mid-2025 divestment of the Paradigm Spine business.

Trivium Shaped is built using Xtant’s PureLoc technology, an automated process that produces elongated, uniform cortical fibres which form the structural backbone of the allograft. The finished matrix combines those fibres with cancellous bone and demineralised bone matrix in a single product. Distribution runs through Xtant’s existing commercial network, with the pre-shaped formats sitting alongside the original sculptable Trivium product introduced last year.

President and CEO Sean Browne said the launch reflects Xtant’s commitment to giving surgeons versatile, high-performance options, with pre-formed configurations chosen to drive consistent surgical outcomes while removing theatre preparation steps. Xtant positions the Trivium line across its core orthobiologics segments, including chronic and surgical wound care, sports medicine and spinal applications.

The launch follows a strategic narrowing of focus for the business. In July 2025, Companion Spine acquired Xtant’s Coflex Interlaminar Stabilization device, the CoFix Posterior MIS fusion system and the Paradigm Spine business, concentrating Xtant’s remaining resources on its orthobiologics franchise rather than implantable spine systems.

Trivium Shaped is a deliberate product extension rather than a leap, but the commercial signal matters more than the technical novelty. Post-divestment, Xtant’s growth ambitions now rest on tightly defined orthobiologics segments, and Trivium franchise expansion looks set to be the central plank of how the company demonstrates that the streamlined, single-focus strategy can drive revenue at scale.